Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders
Nanomaterials · 23.11.2023 · 13 (23) · 3004
DOI: 10.3390/nano13233004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 23.11.2023. Verfasst von Yu Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The lack of effective treatments for neurodegenerative diseases (NDs) is an important current concern. Lipid nanoparticles can deliver innovative combinations of active molecules to target the various mechanisms of neurodegeneration. A significant challenge in delivering drugs to the brain for ND treatment is associated with the blood–brain barrier, which limits the effectiveness of conventional drug administration. Current strategies utilizing lipid nanoparticles and cell-penetrating peptides, characterized by various uptake mechanisms, have the potential to extend the residence time and bioavailability of encapsulated drugs. Additionally, bioactive molecules with neurotropic or neuroprotective properties can be delivered to potentially mediate the ND targeting pathways, e.g., neurotrophin deficiency, impaired lipid metabolism, mitochondrial dysfunction, endoplasmic reticulum stress, accumulation of misfolded proteins or peptide fragments, toxic protein aggregates, oxidative stress damage, and neuroinflammation. This review discusses recent advancements in lipid nanoparticles and CPPs in view of the integration of these two approaches into nanomedicine development and dual-targeted nanoparticulate systems for brain delivery in neurodegenerative disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France.
ORCID-Profile: Angelina Angelova
Zitieren
APA
Wu, Y., & Angelova, A. (2023). Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders. Nanomaterials, 13(23), 3004. https://doi.org/10.3390/nano13233004
Vancouver
Wu Y, Angelova A. Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders. Nanomaterials. 2023;13(23):3004. doi:10.3390/nano13233004
BibTeX
@article{Wu2023,
author = {Wu, Yu and Angelova, Angelina},
title = {Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders},
journal = {Nanomaterials},
year = {2023},
volume = {13},
number = {23},
pages = {3004},
doi = {10.3390/nano13233004}
}
EUVIMED